| Dr Taarif Hussain, MD FAAFP | |
|
416 E Maumee St, Angola, IN 46703-2015 | |
| (260) 498-2020 | |
| Not Available |
| Full Name | Dr Taarif Hussain |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 416 E Maumee St, Angola, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770716680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 60272125 (Washington) | Secondary |
| 207P00000X | Emergency Medicine | 01081471A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Noble Hospital | Kendallville, IN | Hospital |
| Parkview Lagrange Hospital | Lagrange, IN | Hospital |
| Parkview Whitley Hospital | Columbia city, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Emergency Physicians Pc | 2769384213 | 25 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Professional Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144215096 PECOS PAC ID: 2769384213 Enrollment ID: O20040123000999 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Sound Physicians Of Indiana, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528311149 PECOS PAC ID: 4981841780 Enrollment ID: O20130515000624 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Community Hospital Of Lagrange County, Inc. |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1679674956 PECOS PAC ID: 1355382706 Enrollment ID: O20140318000136 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720416555 PECOS PAC ID: 7719119965 Enrollment ID: O20140422001842 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Entity Name | Parkview Wabash Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245259878 PECOS PAC ID: 0244553360 Enrollment ID: O20141222002050 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Taarif Hussain, MD FAAFP 608 Union Chapel Rd, Fort Wayne, IN 46845-9357 Ph: (605) 179-2902 | Dr Taarif Hussain, MD FAAFP 416 E Maumee St, Angola, IN 46703-2015 Ph: (260) 498-2020 |
News Archive
Net Enforcers, one of the nation's leading providers of online channel intelligence and brand protection services, announced today the release of a new version of its Web-based client portal designed to help sales and marketing executives analyze detailed information on how their products and brands are marketed by online dealers.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
Research shows it is safe to give antibiotics to mothers after umbilical clamping in C section, to avoid exposure of the baby.
People at risk for osteoarthritis may be able to delay the onset of the disease or even prevent it with simple changes to their physical activity, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
› Verified 1 days ago
Dr. Susan Frayer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 303, Angola, IN 46703 Phone: 260-667-5685 Fax: 260-667-5564 |